A case of exacerbated encephalopathy with stroke-like episodes and lactic acidosis triggered by metformin in a patient with MELAS

Neurol Sci. 2024 May;45(5):2337-2339. doi: 10.1007/s10072-024-07343-9. Epub 2024 Jan 24.

Abstract

Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a maternally inherited multisystemic disorder caused by mutations in mitochondrial DNA that result in cellular energy deficiency. MELAS affects the most metabolically active organs, including the brain, skeletal muscles, cochlea, retina, heart, kidneys, and pancreas. As a result, about 85% of carriers of m.3243A > G, the most common mutation in MELAS, develop diabetes by the age of 70. Although metformin is the most widely prescribed drug for diabetes, its usefulness in mitochondrial dysfunction remains controversial. Here, we present the case of a 32-year-old Korean patient diagnosed with MELAS who presented with exacerbated stroke-like episodes and lactic acidosis triggered by metformin.

Keywords: DNA, Mitochondrial; MELAS syndrome; Metformin; Point mutation; Seizures.

Publication types

  • Case Reports

MeSH terms

  • Acidosis, Lactic* / chemically induced
  • Adult
  • DNA, Mitochondrial / genetics
  • Diabetes Mellitus
  • Humans
  • MELAS Syndrome* / complications
  • Metformin* / adverse effects
  • Mutation
  • Republic of Korea
  • Stroke*

Substances

  • DNA, Mitochondrial
  • Metformin